Stockholm, November 2, 2015 — Nasdaq (Nasdaq: NDAQ) announced that Hansa Medical AB (short name: HMED), a small cap company within the health care sector, has started trading of its shares on the main market of Nasdaq Stockholm. Hansa Medical is the 75th company to list at Nasdaq’s Nordic markets* in 2015.
Hansa Medical is a biopharmaceutical company focusing on novel immunomodulatory enzymes. The lead project IdeS is an antibody-degrading enzyme in clinical development, with potential use in transplantation and rare autoimmune diseases. Other projects include EndoS, an antibody-modulating bacterial enzyme in pre-clinical development, and HBP, a market introduced diagnostic biomarker for severe sepsis. Hansa Medical is headquartered in Lund, Sweden. For more information, please visit www.hansamedical.com.
“During 2015 we have made significant progress in our prioritized clinical development programs” said Göran Arvidson, President and CEO of Hansa Medical AB. “Our vision is to build a sustainable biopharmaceutical company with pharmaceuticals that significantly improve health outcomes in patients. We are getting the cornerstones in place for future growth. The upgrade to Nasdaq Stockholm’s main market has the potential to make Hansa Medical even more attractive to existing and new potential investors.”
“We are excited to welcome Hansa Medical to the Nasdaq Stockholm main market,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “Hansa Medical joins our growing healthcare sector and we look forward to supporting them with the increased investor visibility that comes with a main market listing.”
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit nasdaq.com/ambition or business.nasdaq.com.
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact:|
|Christina Malmberg Hägerstrand|
|+46 8 405 65 83|
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.